Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
about
Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM).Specific association of glycoprotein B with lipid rafts during herpes simplex virus entryVaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycansThe herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.Complement evasion by human pathogens.Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1.Complement Evasion Strategies of Viruses: An Overview.Mathematical modeling of herpes simplex virus distribution in solid tumors: implications for cancer gene therapy.In vivo importance of heparan sulfate-binding glycoproteins for murid herpesvirus-4 infection.Herpes simplex virus glycoprotein B binds to cell surfaces independently of heparan sulfate and blocks virus entryCandidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread.Herpes simplex virus type 1 evades the effects of antibody and complement in vivoHerpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humansExcoecarianin, Isolated from Phyllanthus urinaria Linnea, Inhibits Herpes Simplex Virus Type 2 Infection through Inactivation of Viral Particles.Function of herpes simplex virus type 1 gD mutants with different receptor-binding affinities in virus entry and fusionA Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensPatient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.Complement Opsonization Promotes Herpes Simplex Virus 2 Infection of Human Dendritic Cells.HSV-1 exploits the innate immune scavenger receptor MARCO to enhance epithelial adsorption and infection.Regulation of HSV glycoprotein induced cascade of events governing cell-cell fusion.Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs.Human cytomegalovirus infection and atherothrombosis.Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan InteractionViral-derived complement inhibitors: current status and potential role in immunomodulation.Detection of anatid herpesvirus 1 gC gene by TaqMan fluorescent quantitative real-time PCR with specific primers and probe.Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding.Characterization of the gene encoding glycoprotein C of duck enteritis virus.Multivalent binding of herpesvirus to living cells is tightly regulated during infection
P2860
Q24538731-5F3327F4-F65C-4D59-8617-FA6E7897C713Q24683262-3E784591-49AA-431D-96EC-70A7F8E3DA47Q27488704-5BA616F5-C17A-48A6-A2B6-4DF46807491BQ33610941-03401715-E784-4F16-AC76-E3762EDA623AQ33623972-9B17FE92-6086-41CA-B0C8-5D73C26C2E6DQ33788855-8F6676E6-F28F-42C1-A6F3-A6E96A9134A1Q33804431-117956E7-9E10-452B-9E54-AE54606DB500Q33857937-A3BD1020-0655-4692-86AE-4C85385C0B69Q33910764-42CA6EB4-F092-4E8F-ABEA-272AE8882FB2Q33987520-0F8B93AE-81EC-4F87-A5BD-7E9EFFAF68B9Q34141544-FC7E7CB2-2017-48EF-B756-464B2512B874Q34345831-4D740C94-6118-4C03-A6AF-1656884F3239Q34545821-310BF4DE-24FB-46ED-ABA4-D9B5A4838102Q34593833-499D4B71-B403-41AB-800E-62DA1DFF812BQ35105400-4AA6F4CB-49FF-4D72-BF5D-BA9AC898889FQ35182202-C2EF23FA-1B43-412F-8C95-8E229F620844Q35914367-93D4349F-7295-49BC-8C98-00CEF5E9DC48Q35973512-6142ED2F-C43D-4198-9D8C-3B00628EFD0AQ36878921-17B25E0C-4FDD-4BB4-9349-B87A64AFA752Q36925941-33C1C3F4-37D4-420D-A277-99E7C4DB6EC3Q37415391-512C03BB-23E1-497D-9D95-67E51F2F5987Q37547107-3409E030-72CD-4FBB-9B30-905065176733Q37967568-4CF168DF-619C-4782-9CCF-1D4F2E168A49Q38854789-63731AFA-7393-44B7-AAFA-FE0BA5AA4D1BQ38995165-0095A502-C227-4932-B86E-8DAEFBD4A6E0Q39594070-F3A6639B-603A-4132-827E-AAA69AFDCCE4Q41873760-8C46287A-0247-4568-93C7-004EEDEB97AFQ42664630-D0EAE447-6220-485E-AB42-969905330673Q57016583-AF1C9D1E-B644-41F8-99F8-A2C6D6D451F4
P2860
Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Kinetic analysis of glycoprote ...... and complement component C3b.
@en
Kinetic analysis of glycoprote ...... and complement component C3b.
@nl
type
label
Kinetic analysis of glycoprote ...... and complement component C3b.
@en
Kinetic analysis of glycoprote ...... and complement component C3b.
@nl
prefLabel
Kinetic analysis of glycoprote ...... and complement component C3b.
@en
Kinetic analysis of glycoprote ...... and complement component C3b.
@nl
P2093
P356
P1433
P1476
Kinetic analysis of glycoprote ...... and complement component C3b.
@en
P2093
Gary H Cohen
Harvey M Friedman
P304
P356
10.1006/VIRO.2001.1326
P407
P577
2002-03-01T00:00:00Z